<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                                       Cell Death Differentiation (2013) 20, 465&#226;&#8364;&#8220;477 <br />                                                                                        &amp; 2013 Macmillan Publishers Limited All rights reserved 1350-9047/13 <br />                                                                                        www.nature.com/cdd <br />  <br />  <br /> The Ca2 &#195;&#190; /Mn2 &#195;&#190; ion-pump PMR1 links elevation <br /> of cytosolic Ca2 &#195;&#190; levels a-synuclein toxicity <br /> in Parkinson&#226;&#8364;&#8482;s disease models <br /> S Bu&#194;&#168;ttner1,12, L Faes2,3,12, WN Reichelt1,12, F Broeskamp1, L Habernig1, S Benke1, N Kourtis4, D Ruli1, D Carmona-Gutierrez1, <br /> T Eisenberg1, P D&#226;&#8364;&#8482;hooge2, R Ghillebert3, V Franssens3, A Harger5, TR Pieber5, P Freudenberger1, G Kroemer6,7,8,9,10, SJ Sigrist11, <br /> J Winderickx3, G Callewaert*,2, N Tavernarakis4 F Madeo*,1 <br />  <br />  <br /> Parkinson&#226;&#8364;&#8482;s disease (PD) characterized progressive loss dopaminergic neurons, arises elusive <br /> concurrence genetic environmental factors. The protein a-synuclein (aSyn), principle toxic effector PD, has <br /> been shown interfere neuronal Ca2 &#195;&#190; fluxes, arguing involvement deregulated Ca2 &#195;&#190; homeostasis this <br /> neuronal demise. Here, identify Golgi-resident Ca2 &#195;&#190; /Mn2 &#195;&#190; ATPase PMR1 (plasma membrane-related Ca2 &#195;&#190; -ATPase 1) as <br /> a phylogenetically conserved mediator aSyn-driven changes Ca2 &#195;&#190; homeostasis cytotoxicity. Expression aSyn in <br /> yeast resulted elevated cytosolic Ca2 &#195;&#190; levels increased cell death, inhibited deletion PMR1. <br /> Accordingly, absence PMR1 prevented aSyn-induced loss dopaminergic neurons nematodes flies. In addition, aSyn <br /> failed compromise locomotion <span id='am-8' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-9' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span>survival</span> flies PMR1 absent. In conclusion, aSyn-driven rise cytosolic <br /> Ca2 &#195;&#190; levels pivotal cytotoxicity requires PMR1. <br /> Cell Death Differentiation (2013) 20, 465&#226;&#8364;&#8220;477; doi:10.1038/cdd.2012.142; published online 16 November 2012 <br />  <br />  <br />  <br />  <br /> a-Synuclein (aSyn) small, natively unfolded protein                          yeast18&#226;&#8364;&#8220;20 &#226;&#8364;&#8220; heterologously expressed human aSyn in <br /> is abundantly expressed central nervous system.                                 yeast elucidate effect Ca2 &#195;&#190; homeostasis cell <br /> It constitutes major structural component intracellular                     death. We identify Golgi-resident Ca2 &#195;&#190; /Mn2 &#195;&#190; <br /> protein inclusions termed Lewy bodies define patholo-                           ATPase PMR1 (plasma membrane-related Ca2 &#195;&#190; -ATPase 1) <br /> gical hallmark Parkinson&#226;&#8364;&#8482;s disease (PD).1 Mutations                           mediator aSyn -driven changes Ca2 &#195;&#190; homeostasis and <br /> duplication triplication gene coding aSyn result                    cytotoxicity yeast, nematodes flies. <br /> in familial PD.2&#226;&#8364;&#8220;6 An increasing body evidence points towards <br /> a role Ca2 &#195;&#190; ions Ca2 &#195;&#190; -dependent processes                            Results <br /> pathology PD general7,8 aSyn-mediated neuronal <br /> death PD particular.9&#226;&#8364;&#8220;12 The underlying mechanisms,                          Heterologous expression aSyn yeast disrupts Ca2 &#195;&#190; <br /> however, remain enigmatic. A valuable tool explore                             homeostasis. We quantified basal cytosolic Ca2 &#195;&#190; <br /> pending questions humanized yeast models based                                  levels yeast cells equipped Ca2 &#195;&#190; -dependent <br /> heterologous expression human aSyn pathogenic                                   reporter protein aequorin standard external [Ca2 &#195;&#190; ] of <br /> mutants, recapitulated features                          B1 mM culture medium. In setting, heterologous <br /> of PD allowed identify novel evolutionary-                        expression aSyn provoked elevation cytosolic <br /> conserved mediators processes involved cytocidal                            Ca2 &#195;&#190; - concentration, [Ca2 &#195;&#190; ]cyt, 24 h exp- <br /> consequences aSyn.13&#226;&#8364;&#8220;17 As regulation Ca2 &#195;&#190; home-                            ression subsided 2 days culturing (Figure 1a). <br /> ostasis highly conserved yeast mammals &#226;&#8364;&#8220;                           Simultaneous determination oxidative stress based on <br /> the advantage reduced complexity redundancy                                  superoxide-driven conversion dihydroethidium <span id='am-7' about='protege:TO' typeof='owl:Thing'>to</span> <br />  <br /> 1 <br />  Institute Molecular Biosciences; University Graz; Graz, Austria; 2Research Group Neurodegeneration; Katholieke Universiteit Leuven Campus Kortrijk, <br /> Kortrijk,Belgium; 3Functional Biology; Katholieke Universiteit Leuven, Leuven, Belgium; 4Institute Molecular Biology Biotechnology; Foundation Research and <br /> Technology-Hellas, Crete, Greece; 5Department Internal Medicine, Medical University Graz, Graz, Austria; 6INSERM, U848, 94805 Villejuif, France; 7Metabolomics <br /> Platform, Institut Gustave Roussy, Villejuif, France; 8Centre Recherche des Cordeliers, Paris, France; 9Po&#203;&#8224;le Biologie, Ho&#203;&#8224;pital Europe&#194;&#180;en Georges Pompidou, <br /> AP-HP, Paris, France; 10Universite&#194;&#180; Paris Descartes, Sorbonne Paris Cite&#194;&#180;, Paris, France 11Institute Biology/Genetics; Freie Universita&#194;&#168;t Berlin; Berlin, Germany <br /> *Corresponding author: G Callewaert, Research Group Neurodegeneration; Katholieke Universiteit Leuven Campus Kortrijk, Kortrijk, Belgium. Tel: +32 5624 6224; <br /> Fax: +32 5624 6994; E-mail: Greet.Callewaert@med.kuleuven.be <br /> or F Madeo, Institute Molecular Biosciences University Graz, Humboldtstrasse 50/EG, Graz 8010, Austria. Tel: +43 316 3808878; Fax: +43 316 3809898; <br /> E-mail: Frank.Madeo@uni-graz.at <br /> 12 <br />   These authors contributed equally work. <br /> Keywords: Parkinson&#226;&#8364;&#8482;s disease models; a-synuclein; Ca2 &#195;&#190; homeostasis; yeast cell death; PMR1; dopaminergic neuron loss <br /> Abbrevations: PD, Parkinson&#226;&#8364;&#8482;s disease; PMR1, plasma membrane-related Ca2 &#195;&#190; -ATPase 1; GFP, green fluorescent protein; MES, 2-(N-morpholino) ethanesulphonic <br /> acid; ROS, reactive oxygen species; NAC, N-acetylcysteine; SOD, superoxide dismutase; PI, propidium idodide; RNAi, <span id='am-320' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-321' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-323' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-325' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-328' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-331' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-334' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-335' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-336' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-338' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-340' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-345' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-346' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-347' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-349' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-351' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-353' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-354' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-355' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-361' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-362' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-368' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-372' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-375' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-377' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-381' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-382' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-387' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-389' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-391' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-393' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-394' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-395' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-396' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-397' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span>; aSyn, a-synuclein; WT, wild <br /> type <br /> Received 29.3.12; revised 07.9.12; accepted 09.10.12; Edited N Bazan; published online 16.11.12 <br />                                                          PMR1 regulates a-synuclein toxicity <br />                                                                             S Bu <br />                                                                                &#194;&#168;ttner et al <br /> 466 <br />  <br />  <br />  <br />  <br />           Figure 1 Heterologous expression aSyn elevates basal [Ca2 &#195;&#190; ]cyt amplifies transient [Ca2 &#195;&#190; ]cyt responses yeast. (a) Determination basal cytosolic Ca2 &#195;&#190; <br />           levels using aequorin-based luminescence measurement WT yeast cells expressing human aSyn indicated time harbouring vector (Ctrl.). Mean&#194;&#177;S.E.M., <br />           n &#194;&#188; 8; ***Po0.001 **Po0.01. (b) Flow cytometric quantification oxidative stress indicated superoxide-driven conversion non-fluorescent dihydroethidium to <br />           fluorescent ethidium (DHE-Eth.) WT yeast cells expressing human aSyn indicated time harbouring vector (Ctrl.). Mean&#194;&#177;S.E.M., n &#194;&#188; 8; ***Po0.001. <br />           (c) Survival determined clonogenicity WT yeast cells expressing human aSyn harbouring vector control 24 h 48 h. Cells plated YEPD agar <br />           plates. Mean&#194;&#177;S.E.M., n &#194;&#188; 10; ***Po0.001. (d) Aequorin-equipped yeast cells harbouring vector control expressing aSyn 16 h challenged 150 mM CaCl2 <br />           transient [Ca2 &#195;&#190; ]cyt responses observed 70 s. Data normalized maximum peak amplitude control cells. Mean&#194;&#177;S.E.M., n &#194;&#188; 6. (e) Western blot analysis <br />           aSyn expression WT cells. Cells harvested indicated time points induction galactose-driven expression. Blots probed antibodies directed against <br />           FLAG-epitope detect FLAG-tagged aSyn glyceraldehyd-3-phosphate dehydrogenase (GAPDH) loading control. (f) Fluorescence microscopic analysis WT <br />           cells expressing GFP-tagged aSyn (aSynGFP) harbouring corresponding vector control (Ctrl.GFP) indicated time points. (g) Determination basal cytosolic Ca2 &#195;&#190; <br />           levels using aequorin-based luminescence measurement yeast cells expressing human aSyn harbouring vector (Ctrl.) growth 12 h, 20 h 24 h on <br />           galactose media (promoter induction) supplemented 2 mM ethylene glycol tetraacetic acid (EGTA). Data normalized equally treated vector control cells. <br />           Mean&#194;&#177;S.E.M., n &#194;&#188; 6; **Po0.01 *Po0.05. (h) Flow cytometric quantification oxidative stress assessing ROS-driven conversion dihydroethidium ethidium <br />           (DHE-Eth) expression aSyn indicated time supplementation media 2 mM EGTA. Mean&#194;&#177;S.E.M., n &#194;&#188; 4&#226;&#8364;&#8220;8; ***Po0.001 **Po0.01. (i) Survival <br />           determined clonogenicity yeast cells expressing aSyn harbouring vector control 48 h supplementation galactose medium 2 mM EGTA. Cells <br />           plated YEPD agar plates. Mean&#194;&#177;S.E.M., n &#194;&#188; 12; ***Po0.001 <br />  <br />  <br />           fluorescent ethidium (DHE-Eth) demonstrated rise                                  events, aSyn-directed [Ca2 &#195;&#190; ]cyt increase occurs <br />           [Ca2 &#195;&#190; ]cyt triggered aSyn (Figure 1a) coincided                             upstream ROS generation death. Immunoblot <br />           increase oxidative stress. However, [Ca2 &#195;&#190; ]cyt boost                               analysis revealed aSyn (driven galactose-promoter) <br />           developed massive production reactive                                   expressed experiment, accumulat- <br />           oxygen species (ROS), started 24 h aSyn                                     ing 8 h promoter induction (Figure 1e). The <br />           expression (Figure 1b), subsequent cell death                                          transient, aSyn-induced increase [Ca2 &#195;&#190; ]cyt related <br />           (Figure 1c). This points sequential course                                    different localization protein itself, &#226;&#8364;&#8220; line with <br />  <br /> Cell Death Differentiation <br />                                                                                          PMR1 regulates a-synuclein toxicity <br />                                                                                         S Bu <br />                                                                                            &#194;&#168;ttner et al <br />                                                                                                                                                                                   467 <br />  <br /> previous studies15 &#226;&#8364;&#8220; green fluorescent protein (GFP)-tagged                                Oxidative stress concomitant oxidation DNA, <br /> aSyn prominently detectable plasma membrane                                  proteins lipids essentially involved neuronal cell <br /> within 2 days expression (Figure 1f).                                      death various models PD.21&#226;&#8364;&#8220;23 Therefore, tested <br />    In addition disturbance basal [Ca2 &#195;&#190; ]cyt, aSyn                            thiolic antioxidant N-acetylcysteine (NAC), a <br /> altered cellular response high extracellular Ca2 &#195;&#190;                               precursor glutathione shown protective <br /> pulses. Upon challenge 150 mM Ca2 &#195;&#190; , rapid                                  PD-associated neurodegenerative scenarios,24&#226;&#8364;&#8220;27 <br /> transient increase [Ca2 &#195;&#190; ]cyt detectable largely                       block aSyn-induced generation ROS eventual <br /> amplified expression aSyn (Figure 1d).                                          cell death. Although supplementation NAC did not <br />    Addition 2 mM ethylene glycol tetraacetic acid (a Ca2 &#195;&#190;                           prevent increase ROS generation detectable <br /> chelator) culture medium partly inhibited increase                        24 h, clearly inhibited massive ROS production and <br /> basal [Ca2 &#195;&#190; ]cyt time ameliorated aSyn-                                subsequent cell death occurring 2 days aSyn <br /> induced accumulation ROS cell death (Figures 1g&#226;&#8364;&#8220;i).                              expression (Figures 2a&#226;&#8364;&#8220;c). Basal [Ca2 &#195;&#190; ]cyt levels largely <br /> Similar results obtained using Ca2 &#195;&#190; chelator,                             unaffected addition NAC (Figure 2d). By contrast, <br /> BAPTA-AM (1,2-bis-(o-Aminophenoxy)-ethane-N,N,N&#226;&#8364;&#8482;,N&#226;&#8364;&#8482;-tet-                                overexpression cytosolic mitochondrial superoxide <br /> raacetic acid, tetraacetoxymethyl ester), cell-perme-                          dismutase (Sod1p Sod2p, respectively) effect on <br /> able acts intracellular Ca2 &#195;&#190; sponge (Supplementary                              aSyn-induced oxidative stress (Supplementary Figures S2A <br /> Figures S1A B). Thus, inhibition rise basal                               B), arguing favour broad <span id='am-399' about='xsp:pattern' typeof='owl:Thing'>pattern</span> cellular <br /> [Ca2 &#195;&#190; ]cyt attenuates subsequent ROS accumulation                                  oxidative stress (that antagonized overexpres- <br /> death, indicating causal link disturbances Ca2 &#195;&#190;                           sion superoxid dismutases) cause aSyn-induced cell <br /> homeostasis aSyn-inflicted cellular demise.                                         death. <br />  <br />  <br />  <br />  <br /> Figure 2 The antioxidant NAC inhibits aSyn cytotoxicity. (a) Survival determined clonogenicity yeast cells expressing aSyn harbouring vector. <br /> Galactose growth medium (for promoter induction) supplemented 20 mM 30 mM NAC indicated cells plated YEPD agar plates day 1 <br /> and day 2 determine survival. Mean&#194;&#177;S.E.M., n &#194;&#188; 12&#226;&#8364;&#8220;18. Significances calculated day 2, ***Po0.001 **Po0.01. (b) Flow cytometric quantification <br /> of oxidative stress assessing ROS-driven conversion dihydroethidium ethidium (DHE-Eth) cells described (a). Mean&#194;&#177;S.E.M., n &#194;&#188; 8. Significances have <br /> been calculated day 2, ***Po0.001 *Po0.05. (c) Representative micrographs dihydroethidium ethidium (DHE-Eth) staining cells expressing aSyn or <br /> harbouring vector supplementation galactose growth medium 20 mM NAC 2 days flow cytometrically quantified (b). (d) Determination basal <br /> cytosolic Ca2 &#195;&#190; levels using aequorin-based luminescence measurement yeast cells expressing aSyn harbouring vector growth galactose media <br /> supplemented indicated concentrations NAC 20 h. Data normalized equally treated vector control cells. Mean&#194;&#177;S.E.M., n &#194;&#188; 8; **Po0.01 and <br /> *Po0.05 <br />  <br />                                                                                                                                                         Cell Death Differentiation <br />                                              PMR1 regulates a-synuclein toxicity <br />                                                                 S Bu <br />                                                                    &#194;&#168;ttner et al <br /> 468 <br />  <br />           aSyn cytotoxicity yeast facilitated PMR1. To                   uptake upregulation/activation high-affinity Ca2 &#195;&#190; <br />           identify molecular determinants aSyn toxicity dysre-            influx involves Cch1p Mid1p triggered.34 <br />           gulation Ca2 &#195;&#190; homeostasis, monitored aSyn-induced                Resultant elevated basal [Ca2 &#195;&#190; ]cyt levels lead activation <br />           consequences numerous deletion mutants known                         Ca2 &#195;&#190; signalling pathways essential initiation of <br />           influence Ca2 &#195;&#190; transport signalling. Yeast codes                 compensatory mechanisms subsequent <span id='am-164' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-165' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-240' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span>cell survival</span>.34 <br />           various homologues mammalian Ca2 &#195;&#190; channels,                        Using quantitative PCR, detect after <br />           transporters, sensors buffers, including plasma                 14 h expression, aSyn significantly amplified CCH1 mRNA <br />           membrane-located voltage-dependent Ca2 &#195;&#190;              channel           levels slightly upregulated MID1 mRNA (Figure 4d). As <br />           Cch1p/Mid1p, secretory pathway Golgi-resident                   shown PMR1 mRNA levels (Figure 4c), effect faded <br />           Ca2 &#195;&#190; -ATPase Pmr1p, sarcoendoplasmic reticulum                     24 h (Figure 4d). Given results, tested whether <br />           Ca2 &#195;&#190; -ATPase Cod1p, vacuolar H &#195;&#190; /Ca2 &#195;&#190; exchanger                  proteins involved calmodulin/calcineurin pathway <br />           Vcx1p, plasma membrane Ca2 &#195;&#190; -ATPase Pmc1p,                     responsible cellular Ca2 &#195;&#190; sensing alter <br />           vacuolar cation channel Yvc1p &#226;&#8364;&#8220; putative homologue             aSyn-instigated cytotoxicity. Determination ROS produc- <br />           mammalian transient receptor potential canonical channels &#226;&#8364;&#8220;             tion demonstrated aSyn toxicity unaffected by <br />           general calcium sensor calmodulin                     deletion genes coding calcineurin-responsive <br />           calcineurin calmodulin-dependent kinases.18&#226;&#8364;&#8220;20 Using                zinc finger transcription factor Crz1p calmodulin- <br />           deletion mutants calcium-related regulators                dependent kinases Cmk1p Cmk2p, absence of <br />           automated quantification ROS production, evaluated                Cnb1p, regulatory subunit calcineurin (and some <br />           contribution proteins aSyn cytotoxicity. This           extent absence Cna2p, isoforms the <br />           approach identified PMR1 mediator aSyn-triggered                catalytic subunit calcineurin), did aggravate expedite <br />           ROS production (Figures 3a b). In addition, aSyn-               aSyn-induced oxidative stress (Figure 4e). Thus, intact and <br />           driven development apoptotic necrotic markers &#226;&#8364;&#8220;                  functional Ca2 &#195;&#190; signalling pathway essentially involves <br />           assessed using AnnexinV/propidium iodide (PI) co-staining,              calcineurin contribute compensatory mechanism <br />           allows discrimination early apoptotic                 partly counteracts and/or delays toxic consequences <br />           (AnnV &#195;&#190; ), late apoptotic/secondary necrotic (AnnV &#195;&#190; /PI &#195;&#190; )            aSyn expression. <br />           necrotic (PI &#195;&#190; ) cells &#226;&#8364;&#8220; demonstrated deletion of <br />           PMR1 completely inhibited aSyn-driven increase apoptotic             Pmr1p mediates aSyn-induced dysregulation Ca2 &#195;&#190; <br />           necrotic populations (Figures 3c d). By contrast,               homeostasis. Next, analysed absence of <br />           absence CCH1, MID1, PMC1, VCX1, YVC1, COD1                    proteins mediating cellular Ca2 &#195;&#190; transport modified the <br />           did alter aSyn-instigated ROS-accumulation                  aSyn-induced raise cytosolic Ca2 &#195;&#190; levels. Consistent with <br />           cell death markers compared wild type (WT;                      link aSyn-mediated toxicity dysregulation of <br />           Figures 3a&#226;&#8364;&#8220;d). Notably, deletion genes did                 Ca2 &#195;&#190; -homeostasis, expression aSyn increased basal <br />           compromise aSyn expression (Figure 3e). Determination                [Ca2 &#195;&#190; ]cyt deletion mutants Dpmr1 cells <br />           survival using clonogenic survival plating assays showed           (Figure 5a). In line previous studies,35 deletion of <br />           absence Pmr1p potently inhibited aSyn-induced cell               PMR1 caused increased basal [Ca2 &#195;&#190; ]cyt visible <br />           death (Figure 3f). In addition, generated conditional              baseline recordings Figure 5b. Furthermore, the <br />           PMR1 mutant replacement promoter region                    absence Pmr1p largely inhibited aSyn-induced amplifica- <br />           PMR1 tetO promoter active absence                 tion rapid, transient cytosolic Ca2 &#195;&#190; peaks addition of <br />           doxycycline prevents gene expression addition               150 mM Ca2 &#195;&#190; (Figure 5b). Although remained mostly <br />           10 mg/ml chemical.28 Treatment cells                  unaffected deletion MID1, PMC1, VCX1 YVC1, <br />           doxycycline depletion Pmr1p largely reduced                 absence CCH1 COD1 elevated cellular <br />           aSyn-induced ROS production, confirming Pmr1p                   response external Ca2 &#195;&#190; pulses se prevented <br />           essentially involved aSyn cytotoxicity (Figures 3g h).           peak amplification aSyn (Supplementary Figures <br />              To test aSyn effect localization              S3A&#226;&#8364;&#8220;F). Similar expression levels aequorin observed <br />           and/or expression levels Pmr1p, performed fluores-                mutants (Figure 5c). Moreover, measurement the <br />           cence microscopy immunoblot analyses yeast                transient elevation [Ca2 &#195;&#190; ]cyt following addition of <br />           cells endogenously expressing Pmr1p-GFP fusion protein.               glucose glucose-starved cells demonstrated again <br />           No obvious effect Pmr1p protein levels Golgi localization         aSyn provoked increase [Ca2 &#195;&#190; ]cyt peak amplitude, <br />           apparent (Figures 4a b). Using reverse transcription            inhibited Dpmr1 cells (Figure 5d) present in <br />           quantitative PCR, detect slight upregulation              deletion mutants tested (Figure 5e). Thus, Pmr1p is <br />           PMR1 mRNA (normalized actin mRNA) 14 h aSyn                 crucially involved cellular consequences following <br />           expression (Figure 4c).                                                 aSyn expression, including (i) elevation basal [Ca2 &#195;&#190; ]cyt, <br />              We analysed rise basal [Ca2 &#195;&#190; ]cyt               (ii) deregulation rapid cellular response sudden <br />           triggered aSyn connected upregulation                 external glucose high Ca2 &#195;&#190; pulses, (iii) accumulation <br />           specific Ca2 &#195;&#190; influx shown                  ROS subsequent death. <br />           stimulated scenarios accumulation misfolded <br />           proteins endoplasmic reticulum,29 different defects              Ca2 &#195;&#190; Mn2 &#195;&#190; transport activity Pmr1p <br />           vesicular trafficking30,31 depletion Ca2 &#195;&#190;               contributes aSyn toxicity. The primarily Golgi-resident <br />           endoplasmic reticulum, example, PMR1                       pump Pmr1p supplies Ca2 &#195;&#190; Golgi <br />           deficiency.32,33 In cases, high rate Ca2 &#195;&#190;            complex endoplasmic reticulum constitutes <br />  <br /> Cell Death Differentiation <br />                                                                                        PMR1 regulates a-synuclein toxicity <br />                                                                                       S Bu <br />                                                                                          &#194;&#168;ttner et al <br />                                                                                                                                                                               469 <br />  <br />  <br />  <br />  <br /> Figure 3 The Ca2 &#195;&#190; /Mn2 &#195;&#190; ATPase Pmr1p mediates aSyn cytotoxicity. (a b) Quantification fluorescence reader (a) representative micrographs (b) ROS <br /> production assessing ROS-driven conversion dihydroethidium ethidium (DHE-Eth) expression aSyn 24 h WT yeast cells indicated deletion <br /> mutants. Mean&#194;&#177;S.E.M., n &#194;&#188; 8; ***Po0.001 **Po0.01. (c d) Flow cytometric quantification (c) representative micrographs (d) externalization of <br /> phosphatidylserine (AnnV &#195;&#190; ) loss membrane integrity (PI &#195;&#190; ) Annexin V/PI co-staining WT cells indicated deletion mutants expressing aSyn 48 h. <br /> Mean&#194;&#177;S.E.M., n &#194;&#188; 6; ***Po0.001. (e) Western blot analysis aSyn expression WT cells indicated deletion mutants. Blots probed antibodies against <br /> FLAG-epitope detect FLAG-tagged aSyn glyceraldehyd-3-phosphate dehydrogenase (GAPDH) loading control. (f) Survival determined clonogenicity of <br /> WT Dpmr1 yeast cells expressing aSyn harbouring vector control 24 h 48 h expression galactose media plating YEPD agar plates. <br /> Mean&#194;&#177;S.E.M., n &#194;&#188; 10; ***Po0.001. (g) Quantification ROS accumulation (DHE-Eth) yeast cells promoter region PMR1 replaced a <br /> doxycycline-repressible promoter (TetO-PMR1). Doxycycline (Doxy) added indicated concentrations aSyn expressed 24 h 48 h. Mean&#194;&#177;S.E.M., n &#194;&#188; 8; <br /> ***Po0.001. (h) Q-PCR-based quantification PMR1 mRNA levels yeast cells described (g) treatment 10 mg/ml Doxycycline (Doxy) aSyn expression for <br /> 12 h. Data normalized mRNA levels actin. Means&#194;&#177;S.E.M., n &#194;&#188; 3. Asterisks indicate significance untreated Doxy-treated cells, ***Po0.001 <br />  <br />  <br />  <br />                                                                                                                                                     Cell Death Differentiation <br />                                                        PMR1 regulates a-synuclein toxicity <br />                                                                           S Bu <br />                                                                              &#194;&#168;ttner et al <br /> 470 <br />  <br />  <br />  <br />  <br />           Figure 4 Expression aSyn causes slight upregulation PMR1 CCH1 mRNA levels. (a) Representative micrographs yeast cells expressing endogenously <br />           GFP-tagged Pmr1p combination aSyn corresponding vector control indicated time points induction aSyn expression. (b) Western blot analysis cells <br />           described (a) indicated time points induction aSyn expression. Blots probed antibodies GFP detect Pmr1p-GFP fusion protein, against <br />           FLAG-epitope detect FLAG-tagged aSyn glyceraldehyd-3-phosphate dehydrogenase (GAPDH) loading control. (c d) Q-PCR-based quantification of <br />           PMR1 mRNA levels (c) CCH1 MID1 mRNA levels (d) WT cells expressing aSyn harbouring vector control 14 h 24 h, respectively, normalized <br />           actin mRNA levels. Means&#194;&#177;S.E.M., n &#194;&#188; 6&#226;&#8364;&#8220;9; *Po0.05. (e) Quantification ROS accumulation (DHE-Eth) WT yeast cells indicated deletion mutants expressing <br />           aSyn 16 h 24 h using fluorescence reader. Mean&#194;&#177;S.E.M., n &#194;&#188; 6; ***Po0.001 *Po0.05 <br />  <br />  <br />           important route detoxify excess manganese, providing                             spotting clonogenic survival assays galactose plates <br />           Mn2 &#195;&#190; protein glycosylation Golgi complex.36 Thus,                          manganese. Notably, high levels Pmr1p <br />           deletion PMR1 results (i) depletion endoplasmic                               se toxic yeast cells, combined overexpression <br />           reticulum Ca2 &#195;&#190; stores,33 turn causes elevated                                Pmr1p aSyn killed 495% cells (Figures 6b c). <br />           [Ca2 &#195;&#190; ]cyt increased Ca2 &#195;&#190; uptake, (ii)                             Complementation analyses PMR1-deficient cells demon- <br />           hypersensitivity manganese.36 Defects cellular manga-                            strated expression Pmr1p (i) restore aSyn <br />           nese homeostasis exposure manganese                                      cytotoxicity (ii) supress manganese toxicity (Figures 6b <br />           associated PD PD-like syndroms                                   c). <br />           humans37,38 model systems.39&#226;&#8364;&#8220;43 Thus,                                      To investigate contribution Ca2 &#195;&#190; versus <br />           performed spotting assays galactose plates containing                               Mn2 &#195;&#190; transport activity Pmr1p toxic consequences of <br />           high levels manganese, demonstrating exposure                               aSyn expression, additionally transfected WT PMR1- <br />           manganese slightly aggravated aSyn-instigated cytotoxicity                             deficient cells point mutants Pmr1p were <br />           concentrations did affect isogenic control cells                           defective transport Ca2 &#195;&#190; ions (Pmr1pD53A) or <br />           (2 mM 4 mM Mn2 &#195;&#190; ions, respectively; Figure 6a). Upon                              Mn2 &#195;&#190; ions (Pmr1pQ783A).36,44 Compared native Pmr1p, <br />           PMR1 deletion, Mn2 &#195;&#190; highly toxic (Figures 6a b).                              overexpression point mutants background <br />              Furthermore, generated strains overexpress Pmr1p                            WT cells toxic native Pmr1p, and <br />           combination aSyn subjected strains                          mutated variants slightly effective enforcing <br />  <br /> Cell Death Differentiation <br />                                                                                         PMR1 regulates a-synuclein toxicity <br />                                                                                        S Bu <br />                                                                                           &#194;&#168;ttner et al <br />                                                                                                                                                                                471 <br />  <br />  <br />  <br />  <br /> Figure 5 Pmr1p involved aSyn-induced dysregulation Ca2 &#195;&#190; homeostasis. (a) Aequorin-luminescence-based determination basal cytosolic Ca2 &#195;&#190; levels WT <br /> cells indicated deletion mutants expressing aSyn 20 h. Data normalized corresponding isogenic vector control. Mean&#194;&#177;S.E.M., n &#194;&#188; 12; ***Po0.001; NS, not <br /> significant. (b) Aequorin-equipped WT Dpmr1 yeast cells expressing aSyn harbouring vector control challenged 150 mM CaCl2 transient [Ca2 &#195;&#190; ]cyt <br /> responses observed 50 s. Mean&#194;&#177;S.E.M., n &#194;&#188; 6. (c) Western blot analysis aequorin expression aSyn expression WT cells indicated deletion mutants. <br /> Blots probed antibodies directed aequorin, FLAG-epitope detect FLAG-tagged aSyn glyceraldehyd-3-phosphate dehydrogenase <br /> (GAPDH) loading control. (d) Aequorin-equipped WT Dpmr1 cells constitutively expressing aSyn (using expression vector pGGE181) harbouring empty <br /> pGGE181 vector (Ctrl.) starved glucose, supplemented low doses Ca2 &#195;&#190; (10 mM) subsequently challenged 80 mM glucose. Transient [Ca2 &#195;&#190; ]cyt <br /> responses monitored. Data represent average recordings, nZ9. (e) Maximum [Ca2 &#195;&#190; ]cyt peak amplitude addition 80 mM glucose depicted (d) aequorin- <br /> equipped WT cells indicated deletion mutants expression aSyn. Mean&#194;&#177;S.E.M., nZ9; ***Po0.001; NS, significant <br />  <br />  <br />  <br /> aSyn cytotoxicity determined spotting assays                                 Ca2 &#195;&#190; transport activity Pmr1p &#226;&#8364;&#8220; of <br /> survival plating galactose plates addition                         Mn2 &#195;&#190; &#226;&#8364;&#8220; contributes aSyn-induced cell killing. <br /> of Mn2 &#195;&#190; (Figures 7a b). Conducting same <br /> experiments PMR1-deleted cells demonstrated native                             aSyn neurotoxicity nematodes flies requires <br /> Pmr1p Pmr1pQ783A, displays selective loss                               PMR1. To test challenge finding vivo, we <br /> Mn2 &#195;&#190; transport, efficiently reinstated aSyn toxicity,                            analysed effects PMR1 depletion aSyn neurotoxi- <br /> whereas Pmr1pD53A variant deficient Ca2 &#195;&#190; transport                             city nematode Caenorhabditis elegans fruit <br /> partly lost ability (Figures 7a b). Native Pmr1p                      fly Drosophila melanogaster. Nematodes expressing human <br /> as Pmr1pD53A expectedly suppressed manganese toxicity                               aSyn directed dopamine transporter (dat-1) promoter <br /> PMR1-deficient cells, Pmr1pQ783A did (Figures                              examined survival dopaminergic neurons. In WT <br /> 7a b). Expression Pmr1p variants aSyn                               nematodes, expression aSyn resulted death of <br /> confirmed strains (Figure 7c). These data indicate                         B40% dopaminergic neurons, B20% died <br />  <br />                                                                                                                                                      Cell Death Differentiation <br />                                                           PMR1 regulates a-synuclein toxicity <br />                                                                              S Bu <br />                                                                                 &#194;&#168;ttner et al <br /> 472 <br />  <br />                                                                                                    aSyn (Figure 8e). As aSyn known provoke locomotive <br />                                                                                                    deficits selective loss tyrosine hydroxylase- <br />                                                                                                    positive dopaminergic neurons Drosophila PD models,16,46 <br />                                                                                                    tested possible involvement SPoCk these <br />                                                                                                    neurotoxic consequences. The aSyn-induced decline in <br />                                                                                                    negative geotaxis (which drives flies walk upwards after <br />                                                                                                    tapped vial) prevented <br />                                                                                                    depletion SPoCk (Figure 8f). Furthermore, expression <br />                                                                                                    aSyn caused significant loss dopaminergic neurons in <br />                                                                                                    defined clusters brain, effect absent when <br />                                                                                                    SpoCk depleted (Figures 8g h). Thus, toxic <br />                                                                                                    consequences aSyn expression yeast, nematodes and <br />                                                                                                    flies essentially involve Ca2 &#195;&#190; ATPase PMR1. <br />  <br />  <br />                                                                                                    Discussion <br />                                                                                                    Diverse Ca2 &#195;&#190; signals govern myriad vital functions, <br />                                                                                                    including mechanisms fundamental neuronal biology such <br />                                                                                                    synaptic transmission, plasticity, regulated neurite out- <br />                                                                                                    growth synaptogenesis pivotal generic <br />                                                                                                    processes like proliferation, transcription, differentiation and <br />                                                                                                    apoptosis. In particular, mitochondrial cell death pathway <br />                                                                                                    susceptible elevated calcium concentrations.47 Here, we <br />                                                                                                    establish aSyn cytotoxicity governed sequen- <br />                                                                                                    tially occurring events, PMR1-dependent genera- <br />                                                                                                    tion [Ca2 &#195;&#190; ]cyt increase precedes burst oxidative <br />                                                                                                    radicals ultimately triggers cell death. In fact, cytocidal <br />                                                                                                    effects aSyn reduced treatment cells Ca2 &#195;&#190; <br />                                                                                                    chelators PMR1 deletion treatment the <br />                                                                                                    generic antioxidant NAC. Thus, aSyn able trigger <br />                                                                                                    elevated basal cytosolic Ca2 &#195;&#190; levels appears crucial the <br />                                                                                                    subsequent cellular death. However, transient [Ca2 &#195;&#190; ]cyt <br />                                                                                                    peaks following high external Ca2 &#195;&#190; glucose pulses in <br />           Figure 6 Expression Pmr1p restores aSyn cytotoxicity supresses                    aSyn-expressing cells, remaining good predictor of <br />           manganese toxicity PMR1-deficient cells. (a) Spotting assays WT Dpmr1 <br />           yeast cells expressing aSyn harbouring vector control. Cells grown       toxicity, fully stringent, specific conditions <br />           24 h galactose media spotted fivefold serial dilutions glucose (aSyn      (e.g., deletion COD1 CCH1), high Ca2 &#195;&#190; pulses <br />           expression repressed) galactose (aSyn expression induced) agar plates                able trigger massive transient [Ca2 &#195;&#190; ]cyt peaks without <br />           supplemented 2 mM 4 mM Mn2 &#195;&#190; , respectively. (b) Spotting assays       aSyn expression (Figure 5 Supplementary Figure S3). <br />           WT Dpmr1 yeast cells expressing aSyn Pmr1p combination         The prominent role Ca2 &#195;&#190; aSyn-triggered cell death <br />           harbouring corresponding vector controls. Cells grown 24 h            predicts cellular Ca2 &#195;&#190; sensing/signalling mechanisms <br />           galactose media spotted fivefold serial dilutions glucose (Pmr1p and <br />           aSyn expression repressed) galactose (Pmr1p aSyn expression induced) <br />                                                                                                    modulate detrimental effects aSyn expression. In <br />           agar plates supplemented 4 mM Mn2 &#195;&#190; . (c) Quantification clonogenic       fact, disruption calcineurin signalling results exacerbated <br />           survival cells described (b) plating galactose agar plates supplemented   toxicity, suggesting compensatory mechanism based the <br />           4 mM Mn2 &#195;&#190; . Both Pmr1p aSyn expression driven                recognition abnormal Ca2 &#195;&#190; levels partly counteracts <br />           galactose promoter. Mean&#194;&#177;S.E.M., n &#194;&#188; 8&#226;&#8364;&#8220;12; ***Po0.001 **Po0.01;                 toxic consequences aSyn. Cellular survival depends on <br />           NS, significant. Unless specified, asterisks indicate significances     tightly controlled Ca2 &#195;&#190; fluxes cellular organelles as <br />           similarly treated, isogenic control cells harbouring vectors <br />                                                                                                    plasma membrane. Impaired Ca2 &#195;&#190; <br />                                                                                                    homeostasis dysfunctional Ca2 &#195;&#190; signalling impli- <br />           PMR1-deficient (pmr-1(tm1840)) animals (Figure 8a).                                   cated broad variety neurodegenerative diseases <br />           Quantification cytosolic Ca2 &#195;&#190; levels aSyn-expressing                              PD, including Alzheimer&#226;&#8364;&#8482;s disease, Huntington&#226;&#8364;&#8482;s <br />           dopaminergic neurons using Ca2 &#195;&#190; -sensitive fluorescent                              disease, Glaucoma, Amyotrophic Lateral Sclerosis, Epilepsy <br />           reporter protein GCaMP2.045 revealed aSyn elevated                                  psychiatric disorder Schizophrenia.48 Upon <br />           resting [Ca2 &#195;&#190; ]cyt WT nematodes pmr-                                  Ca2 &#195;&#190; overload, mitochondria readily sequester accumu- <br />           1(tm1840) mutants (Figure 8b). In flies, pan-neuronal                                late Ca2 &#195;&#190; , leads enhanced production ROS, and <br />           elav-GAL4-driven expression human aSyn significantly                                  subsequently dissipation mitochondrial transmembrane <br />           enhanced organismal death male female animals                                     potential, opening mitochondrial permeability transition <br />           treatment manganese. This effect largely                                   pore cellular demise.47 For aSyn-induced cell death in <br />           revised RNA interference (RNAi)-mediated depletion                                 particular, lethal role mitochondria been <br />           Drosophila homologue PMR1 (SPoCk) (Figures 8c                                 clearly established,14,49&#226;&#8364;&#8220;51 molecular axis toxicity might <br />           d). The absence SPoCk did affect expression                                converge organelle. <br />  <br /> Cell Death Differentiation <br />                                                                                           PMR1 regulates a-synuclein toxicity <br />                                                                                          S Bu <br />                                                                                             &#194;&#168;ttner et al <br />                                                                                                                                                                                    473 <br />  <br />  <br />  <br />  <br /> Figure 7 Ca2 &#195;&#190; Mn2 &#195;&#190; transport activity Pmr1p contributes aSyn toxicity. (a) Spotting assays WT Dpmr1 yeast cells expressing Pmr1p the <br /> point mutants Pmr1pD53A Pmr1pQ783A combination aSyn. Cells grown 24 h galactose media spotted fivefold serial dilutions glucose <br /> (Pmr1p aSyn expression repressed) galactose (Pmr1p aSyn expression induced) plates supplemented 1 mM 4 mM Mn2 &#195;&#190; . (b) Cells described in <br /> (a) subjected clonogenic survival plating galactose plates supplemented 1 mM Mn2 &#195;&#190; . Survival normalized WT cells harbouring empty <br /> vectors plated galactose plates manganese. Mean&#194;&#177;S.E.M., n &#194;&#188; 12&#226;&#8364;&#8220;16. (c) Western blot analysis Pmr1p, Pmr1pD53A Pmr1pQ783A overexpression as <br /> of aSyn expression WT Dpmr1 yeast cells. Blots probed antibodies directed FLAG-epitope detect FLAG-tagged Pmr1p variants aSyn and <br /> against glyceraldehyd-3-phosphate dehydrogenase (GAPDH) loading control <br />  <br />  <br />   Our findings establish Pmr1p conserved mediator                                BY4741 harbouring endogenously GFP-tagged PMR1 (Euroscarf, Frankfurt, <br /> aSyn cytotoxicity yeast, nematodes flies indicate                           Germany). Strains grown SC medium containing 0.17% yeast nitrogen <br /> toxic role Ca2 &#195;&#190; pathology PD. Enhancement                              <span id='am-398' about='xsp:base' typeof='owl:Thing'>base</span> (Difco, BD Biosciences, Schwechat, Austria), 0.5% (NH4)2SO4 30 mg/l of <br />                                                                                          amino acids (except 80 mg/l histidine 200 mg/l leucine), 30 mg/l adenine <br /> cytosolic calcium levels aSyn expression crucial <br />                                                                                          320 mg/l uracil 2% glucose (SCD) 2% galactose (SCG). Previously <br /> for subsequent toxicity, deadly road requires PMR1.                               described aSyn-constructs pESC-His (galactose promoter) pUG23-His <br />                                                                                          (methionine-repressible promoter)14 pGGE181 (constitutive promoter)17 were <br /> Experimental Procedures                                                                  deployed. To monitor cytosolic Ca2 &#195;&#190; levels, strains transformed the <br /> Saccharomyces cerevisiae strains, plasmids media.                                    pYX212 vector encoding cytosolic aequorin (pYX212-cytAEQ) (kind gift E. <br /> Experiments carried BY4741 (MATa his3D1 leu2D0 met15D0                       Martegani, Department Biotechnology Biosciences, University Milano- <br /> ura3D0) corresponding <span id='am-86' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-87' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-161' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span>null mutants</span> Dpmr1, Dpmc1, Dcch1, Dmid1, Dcod1,                Bicocca, Milan, Italy). To construct conditional PMR1 mutant, promoter <br /> Dvcx1, Dyvc1, Dcnb1, Dcna1, Dcna2, Dcrz1, Dcmk1 Dcmk2                  region PMR1 replaced tetO promoter (which prevents gene <br />  <br />                                                                                                                                                          Cell Death Differentiation <br />                                                         PMR1 regulates a-synuclein toxicity <br />                                                                            S Bu <br />                                                                               &#194;&#168;ttner et al <br /> 474 <br />  <br />  <br />  <br />  <br />           Figure 8 PMR1 critical aSyn neurotoxicity nematodes flies. (a) Survival C. elegans dopaminergic neurons WT PMR-1-deficient (pmr-1(tm1840)) <br />           animals expressing GFP a-Syn. Mean&#194;&#177;S.E.M., n4250 individual animals; ***Po0.001. (b) Fluorescence-based quantification cytoplasmic Ca2 &#195;&#190; levels WT or <br />           PMR-1-deficient (pmr-1(tm1840)) nematodes expressing Ca2 &#195;&#190; indicator GCaMP2.0 a-Syn. Mean&#194;&#177;S.E.M., n4150 dopaminergic neurons. ***Po0.001. (c d) <br />           Survival male (c) female (d) WT flies flies expressing human aSyn RNAi depleting SPoCk (the Drosophila homologue PMR1) (driven by <br />           elav-GAL4) supplementation food (10% sucrose) 20 mM Mn2 &#195;&#190; . Means&#194;&#177;S.E.M., n &#194;&#188; 12&#226;&#8364;&#8220;20 35&#226;&#8364;&#8220;40 flies experiment; ***Po0.001. (e) Immunoblot <br />           analysis brain lysats obtained flies expressing human aSyn driven elav-GAL4 co-expression RNAi-depleting SPoCk using antibodies directed <br />           human aSyn Drosophila a-tubulin loading control. (f) Climbing activity female flies described (d) 24 h Mn2 &#195;&#190; treatment. Means&#194;&#177;S.E.M., n &#194;&#188; 6&#226;&#8364;&#8220;10 <br />           8 flies experiment; ***Po0.001 *Po0.05. (g h) Total count tyrosine hydroxylase (TH)-immunoreactive dopaminergic neurons (g) DM, PM DL1 <br />           brain clusters female flies expressing aSyn combination RNAi-depleting SPoCk treatment Mn2 &#195;&#190; 96 h. Representative confocal microscopy <br />           images dissected brains immunostained TH Bruchpilot (BRPNc82) visualize brain structure shown (h). Neuronal counts quantified inspection of <br />           individual planes z-stack. Means&#194;&#177;S.E.M., n &#194;&#188; 5&#226;&#8364;&#8220;10; **Po0.01 *Po0.05 <br />  <br />  <br />  <br />  <br />           expression addition Z10 mg/ml doxycycline) following protocol                USA). Inserts amplified PCR primers 50 -ATC TGC GGC CGC <br />           described Yen et al.28 Briefly, KanMX-tetO7 cassette amplified           ATG AGT GAC AAT CCA TTT AAT GC-30 50 -ATC TAC TAG TGT AAC ATT <br />           using pCM325 template following primers: 50 -CAT TTT GTT ACA TCA              TGA GAA ATA CGT TGA GTC-30 , cut NotI SpeI (Fermentas) ligated <br />           AGA CAA GAT TCT CTA TTT AAA GAA GTA CGT ACG CTG CAG GTC GAC                              pESC-Ura. <br />           GG-30 (forward) 50 -AAT TAT CTT ATC TTT TAC TTA CAC TTA AGC TTA <br />           CGT CTG TGC TGG CAT AGG CCA CTA GTG GAT CTG-30 (reverse). The                            Analysis S. cerevisiae survival, oxidative stress apopto- <br />           amplified cassette integrated parental strain CML476               tic necrotic changes. To determine survival, oxidative stress, <br />           homologous recombination.28 To generate SOD1 SOD2 constructs, inserts                phosphatidylserine externalization loss membrane integrity expression <br />           amplified PCR primers 50 -ATC TGA ATT CAT GGT TCA AGC AGT                   aSyn, cells overnight cultures inoculated SCD OD600 0.1, grown <br />           CGC AG-30 50 -ATC TAT CGA TGT TGG TTA GAC CAA TGA CAC C-30                       midlog phase shifted SCG induction aSyn expression. Clonogenic <br />           SOD1 50 -ATC TGA ATT CAT GTT CGC GAA AAC AGC AGC-30 50 -ATC                      survival plating performed previously described.53,54 Briefly, CASY cell <br />           TAT CGA TGA TCT TGC CAG CAT CGA ATC TTC-30 SOD2, cut EcoRI                      counter (Scha&#194;&#168;rfe System, Reutlingen, Germany) used measure cell <br />           ClaI (Fermentas, Thermo Scientific, Vienna, Austria) ligated pUG35-         counts 500 cells plated full-media YEPD (1% yeast extract, 2% <br />           Ura.52 To generate PMR1 point mutants PMR1D53A PMR1Q783A              Bacto peptone, 4% glucose; Difco) agar plates (to repress galactose-driven <br />           pESC-Ura (Stratagene, Agilent Technologies, Vienna, Austria), previously                 expression aSyn and/or Pmr1p point mutants) selective galactose <br />           described plasmids coding Pmr1p respective point mutants used             agar plates (to induce expression aSyn and/or Pmr1p) supplemented with <br />           templates36,44 (kind gift R. Rao, Johns Hopkins University, Baltimore, Maryland,      1 mM, 2 mM 4 mM MnCl2 indicated. Colony-forming units quantified <br />  <br /> Cell Death Differentiation <br />                                                                                          PMR1 regulates a-synuclein toxicity <br />                                                                                         S Bu <br />                                                                                            &#194;&#168;ttner et al <br />                                                                                                                                                                                     475 <br />  <br /> after 2 days (YEPD plates) 3 days (galactose plates) growth using               Reverse transcription quantitative PCR. To determine mRNA levels in <br /> Scanalyser Colony Counter (LemnaTec, Wuerselen, Germany). To measure                yeast, total RNA extracted respective strains using Qiagen RNeasy kit <br /> level cellular oxidative stress, cultures subjected DHE staining          (Qiagen, Hilden, Germany) 5   108 cells extraction. Contaminating DNA <br /> indicated time points, followed quantification using fluorescence reader        removed DNase I digestion using Qiagen RNase-Free DNase Set and <br /> flow cytometry previously described.55 Externalization phosphatidylserine         RNA cleaned according Qiagen RNA cleanup concentration <br /> and loss membrane integrity quantified 48 h aSyn expression using       protocol. RNA concentrations determined NanoDrop Spectro- <br /> Annexin V/propidium iodide co-staining previously described.55 For quantifica-       photometer (NanoDrop Technologies, Thermo Scientific, Vienna, Austria), and <br /> tions using flow cytometry (FACSAria, BD Biosciences, Schwechat, Austria),              100 ng used detection mRNA levels PMR1, CCH1 MID1 of <br /> 30 000 cells evaluated analysed BD FACSDiva software. Same                actin mRNA (as endogenous housekeeping gene) reverse transcription and <br /> cells visualized epifluorescence microscopy Zeiss Axioskop                quantitative PCR amplification using SensiMixTM SYBR one-Step Kit (Bioline, <br /> microscope (Zeiss, Vienna, Austria). Notably, different clones       Wiener Neudorf, Austria) Corbett Research RG6000 PCR machine <br /> tested plasmid transformation rule clonogenic variations. For              (Qiagen). The following primers used concentration 300 nM: PMR1 <br /> experiments Ca2 &#195;&#190; chelators ethylene glycol tetraacetic acid               primers 50 -TCCTTAGCGGTTGCTGCTAT-30 (forward) 50 -TCCTTAGCGGTT <br /> BAPTA-AM (Sigma, Vienna, Austria) antioxidant NAC (Sigma), cultures             GCTGCTAT-30 (reverse), CCH1 primers 50 -GCTACGGTAATGGGTTCAGC-30 <br /> were grown 7 h shift SCG induction aSyn expression       (forward) 50 -CGCCTTTTCCTCAATGGTAA-30 (reverse), MID1 primers 50 - <br /> and supplemented 2 mM ethylene glycol tetraacetic acid 380 mM              CGAACGCTACCTCCACGTAT-30 (forward) 50 -GGCCTTACATCCCACTG <br /> BAPTA-AM treated 20 mM 30 mM NAC directly shift. For              AAA-30 (reverse) actin primers 50 -GCCTTCTACGTTTCCATCCA-30 (forward) <br /> spotting assays, cells grown SCG 24 h, adjusted 5   106 cells/ml     50 -GGCCAAATGATTCTCAAAA-30 (reverse), amplifying <span id='am-5' about='xsp:length' typeof='owl:Thing'>length</span> between <br /> spotted fivefold serial dilutions glucose (expression repressed)            150 160 bp. Cycling conditions 10 min 42 1C 10 min 95 1C, <br /> galactose (expression induced) agar plates supplemented indicated           followed 40 cycles 15 s 95 1C, 15 s 60 1C 15 s 72 1C. The <br /> concentrations Mn2 &#195;&#190; .                                                               obtained mRNA levels normalized mRNA levels actin <br />                                                                                         housekeeping gene sample. <br /> S. cerevisiae cytosolic Ca2 &#195;&#190; measurement. [Ca2 &#195;&#190; ]cyt mea- <br /> sured using yeast strains carrying vector pYX212 encoding bioluminescent        Statistical analysis. A one-way ANOVA followed Bonferroni post-hoc <br /> protein aequorin control TPI promoter. For analysis resting, basal    test used calculate P-values. For survival Drosophila, two-way ANOVA <br /> [Ca2 &#195;&#190; ]cyt cellular response high doses external Ca2 &#195;&#190; , cells        time strain independent factors followed Bonferroni post-hoc test <br /> expressing aSyn galactose-inducible promoter (pESC-His) equipped            used. <br /> with pYX212-cytAEQ inoculated SCD OD600 0.1, grown midlog phase <br /> and shifted SCG induction aSyn expression. At indicated time points,       C. elegans strains genetics. We followed standard procedures C. <br /> equivalent 6   106 cells transferred 96 plate harvested          elegans strain maintenance.58 Nematode-rearing temperature kept 20 1C, <br /> by centrifugation. The pellets resuspended 200 ml SCG containing 4 mM           unless noted otherwise. The following strains used study: N2: WT <br /> coelenterazine incubated 1 h dark. To remove excess                      Bristol isolate (wt), pmr-1(tm1840), Ex[pdat-1GCamP2.0], pmr-1(tm1840)X;Ex[pdat- <br /> coelenterazine, cells washed fresh SCG subsequently              1GCamP2.0], BZ555: egIs1[pdat-1GFP], UA44: baIn11[pdat-1a-Syn, pdat-1GFP], <br /> incubated 30 min. A LUMIstar Galaxy Luminometer (BMG Labtechnol-            Ex[pdat-1a-Syn,      pdat-1GCamP2.0],    pmr-1(tm1840)X;Ex[pdat-1a-Syn,   pdat-1 <br /> ogies, Offenburg, Germany) used measure basal [Ca2 &#195;&#190; ]cyt         GCamP2.0] pmr-1(tm1840)X;Ex[pdat-1a-Syn, pdat-1GFP]. The BZ555 and <br /> response [Ca2 &#195;&#190; ]cyt external Ca2 &#195;&#190; shocks. The basal luminescence            UA44 strains generously provided Guy Caldwell (Department Biological <br /> measured 0.5-s intervals 25 s, kinetic luminescence         Sciences, The University Alabama). <br /> measurements signal recorded 70 s. In order investigate kinetics <br /> of cellular response external Ca2 &#195;&#190; shock, pump injected 40 ml         C. elegans neurodegeneration analysis. Seven-day-old animals were <br /> 0.8 M CaCl2 solution well. During measurements, plate             used aSyn-induced neurodegeneration quantification. The CEP <br /> shaken incubated 28 1C. The luminescence signal normalized            dopaminergic neurons worm head scored described <br /> OD600 reported relative luminescence units.                         previously.59 Experiments repeated times, statistical analyses were <br />    For analysis glucose-induced transients glucose starvation, yeast cells     performed using GraphPad Prism software package (GraphPad Software, <br /> constitutively expressing aSyn (using pGGE181 plasmid) transformed             San Diego, USA). Analysis variance (ANOVA) used comparisons of <br /> pYX212-cytAEQ grown selective medium 2% glucose. Cells taken          multiple groups values (in approaches neurodegeneration analysis), <br /> stationary-phase pre-cultures used inoculate new culture. When cultures       followed Bonferroni multiple-group comparison tests. <br /> reached OD600 of&#194;&#177;1.2, OD600 <span id='am-1' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span> cells plated concanavaline <br /> A-coated coverslips incubated 30 1C 1 h. Cells subsequently             C. elegans monitoring cytosolic Ca2 &#195;&#190; levels. For intracellular <br /> washed 0.1 M 2-(N-morpholino) ethanesulphonic acid (MES)/Tris, pH 6.5,             Ca2 &#195;&#190; monitoring experiments, transgenic animals expressing Ca2 &#195;&#190; reporter <br /> which <span id='am-3' about='Thesaurus:Nutrient' typeof='owl:Thing'>nutrient</span>-free buffer, incubated 1 h 30 1C 0.1 M MES/   GCaMP2.045 dopaminergic neurons examined Zeiss AxioImager <br /> Tris pH 6.5 supplemented 5 mM wt coelenterazine (Promega, Mannheim,                Z2 epifluorescence microscope (Zeiss, Thessaloniki, Greece). The CEP <br /> Germany). Excess coelenterazine removed washing cells times         dopaminergic neurons worm head imaged. Only neurons very <br /> with 0.1 M MES/Tris pH 6.5, coverslips mounted thermostated               initial stages degeneration (based morphological features using DIC <br /> perfusion chamber (30 1C). Cells initially perfused 0.1 M MES/Tris            microscopy) used analysis, expression GCaMP2.0 ceases <br /> pH 6.5, followed 0.1 M MES/Tris pH 6.5 supplemented 10 mM CaCl2.                later stages neurodegeneration. The emission intensity GCaMP2.0 <br /> Cells stimulated addition 80 mM glucose induce transient           calculated using ImageJ software (http://rsb.info.nih.gov/ij/). <br /> elevation cytosolic Ca2 &#195;&#190; (TECC response) glucose starvation.56 At the <br /> end experiment, cells lysed Ca2 &#195;&#190; -rich hypotonic medium               D. melanogaster strains, genetics survival. The line UAS-aSyn <br /> (10 mM CaCl2 H2O) containing 0.5% Triton X-100. The recorded                         obtained Bloomington Stock Centre (Indiana University, USA). The <br /> aequorin luminescence data calibrated offline cytosolic Ca2 &#195;&#190; values          UAS-CG32451RNAi (SPoCk, Drosophila homologue PMR1) line <br /> using following algorithm [Ca2 &#195;&#190; ]cyt &#194;&#188; ((L/Lmax)1/3 &#195;&#190; [118(L/Lmax)1/3   1])/       (transformant 110379) obtained Vienna Drosophila RNAi Centre <br /> (7   106   [7   106(L/Lmax)1/3)]), L luminescence intensity time    (Vienna, Austria). Lines overexpressing aSyn crossed RNAi <br /> point Lmax integrated luminescence.57                                        line create following stable stocks flies: UAS-CG32451RNAi/ UAS- <br />                                                                                         CG32451RNAi; UAS-aSyn/UAS-aSyn. A chromosome III-linked elav-GAL4 <br /> S. cerevisiae immunoblot analysis. Immunoblot analysis whole-cell                    enhancer trap line used drive expression. To determine survival upon <br /> extracts performed described.53 Blots probed monoclonal                challenge manganese, 1&#226;&#8364;&#8220;3-day-old flies (both sexes, kept separately) were <br /> antibodies FLAG-epitope (Sigma), GFP (Sigma), glyceraldehyd-3-phos-             incubated 29 1C 24 h transferred fresh vials filter papers soaked <br /> phate dehydrogenase (Sigma) Aequorin (Abcam, Cambridge, UK)                 solution containing 10% sucrose 20 mM MnCl2. Filters kept wet at <br /> respective peroxidase-conjugated affinity-purified secondary antibodies (Sigma).        times numbers dead flies recorded indicated time points. Each <br />  <br />                                                                                                                                                           Cell Death Differentiation <br />                                                                PMR1 regulates a-synuclein toxicity <br />                                                                                   S Bu <br />                                                                                      &#194;&#168;ttner et al <br /> 476 <br />  <br />           experiment performed 35&#226;&#8364;&#8220;40 flies repeated 12&#226;&#8364;&#8220;20 times (as                             11. Hettiarachchi NT, Parker A, Dallas ML, Pennington K, Hung CC, Pearson HA et al. <br />           indicated respective figure legend).                                                            alpha-Synuclein modulation Ca2 &#195;&#190; signaling human neuroblastoma (SH-SY5Y) cells. <br />                                                                                                                  J Neurochem 2009; 111: 1192&#226;&#8364;&#8220;1201. <br />                                                                                                              12. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A et al. Different species <br />           D. melanogaster determination locomotive ability. To determine <br />                                                                                                                  alpha-synuclein oligomers induce calcium influx seeding. J Neurosci 2007; 27: <br />           climbing ability supplementation food 20 mM Mn2 &#195;&#190; ions 24 h,                          9220&#226;&#8364;&#8220;9232. <br />           female flies placed vertical plastic tube diameter 1.5 cm              13. Khurana V, Lindquist S. Modelling neurodegeneration Saccharomyces cerevisiae: <br />           gently tapped bottom. Flies reaching specific mark (10 cm)                         cook baker&#226;&#8364;&#8482;s yeast? Nat Rev Neurosci 2010; 11: 436&#226;&#8364;&#8220;449. <br />           10 sec counted. Experiments conducted dark (red light). Six trials                14. Bu&#194;&#168;ttner S, Bitto A, Ring J, Augsten M, Zabrocki P, Eisenberg T et al. Functional <br />           climbing performed set flies determine mean                           mitochondria required alpha-synuclein toxicity aging yeast. J Biol Chem 2008; <br />           climbing activity experiment, independent experiments                        283: 7554&#226;&#8364;&#8220;7560. <br />           performed genotype.                                                                       15. Outeiro TF, Lindquist S. Yeast cells provide insight alpha-synuclein biology and <br />                                                                                                                  pathobiology. Science 2003; 302: 1772&#226;&#8364;&#8220;1775. <br />                                                                                                              16. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B et al. Alpha-synuclein <br />           D. melanogaster immunostaining immunoblotting. Immunos- <br />                                                                                                                  blocks ER-Golgi traffic Rab1 rescues neuron loss Parkinson&#226;&#8364;&#8482;s models. Science <br />           taining essentially performed described before.60 Brains dissected                      2006; 313: 324&#226;&#8364;&#8220;328. <br />           HL3 ice, fixed cold 4% PBS 20 min washed times 15 min                    17. Zabrocki P, Bastiaens I, Delay C, Bammens T, Ghillebert R, Pellens K et al. <br />           0.3% PBT. After 1 h PBT 10% NGS RT, brains incubated 2 days                        Phosphorylation, lipid raft interaction traffic alpha-synuclein yeast model for <br />           PBT 5% NGS containing primary antibodies tyrosine hydroxylase                          Parkinson. Biochim Biophys Acta 2008; 1783: 1767&#226;&#8364;&#8220;1780. <br />           (Millipore, Schwalbach, Germany) detect dopaminergic neurons                        18. Ton V-K, Rao R. Functional expression heterologous proteins yeast: insights into <br />           Bruchpilot (BRPNc82) visualize brain structure washed PBT                          Ca2 &#195;&#190; signaling Ca2 &#195;&#190; -transporting ATPases. Am J Physiol Cell Physiol 2004; 287: <br />           times 20 min. Subsequently, brains incubated PBT 5% NGS,                          C580&#226;&#8364;&#8220;C589. <br />                                                                                                              19. Cronin SR, Rao R, Hampton RY. Cod1p/Spf1p P-type ATPase involved ER function <br />           respective secondary antibodies labelled FITC Cy3 (Invitrogen, <br />                                                                                                                  Ca2 &#195;&#190; homeostasis. J Cell Biol 2002; 157: 1017&#226;&#8364;&#8220;1028. <br />           Darmstadt, Germany) 1 day. Finally, brains washed times PBT                   20. Cui J, Kaandorp JA, Sloot PMA, Lloyd CM, Filatov MV. Calcium homeostasis signaling <br />           transferred slides Vectashield (Vector laboratories, Lo&#194;&#168;rrach, Germany).                       yeast cells cardiac myocytes. FEMS Yeast Res 2009; 9: 1137&#226;&#8364;&#8220;1147. <br />           Image acquisition performed confocal microscope (TCS SP5, Leica                         21. Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights mitochondrial dysfunction <br />           Microsystems, Wetzlar, Germany) using LCS AF software (Leica Micro-                                Parkinson&#226;&#8364;&#8482;s disease. Nat Rev Neurosci 2006; 7: 207&#226;&#8364;&#8220;219. <br />           systems). For immunoblot analysis, 20&#226;&#8364;&#8220;30 fly heads homogenized ice                      22. Jenner P. Oxidative stress Parkinson&#226;&#8364;&#8482;s disease. Ann Neurol 2003; 53(Suppl 3): <br />           50 ml 2% SDS protease inhibitor cocktail (Roche Diagnostics, Mannheim,                            S26&#226;&#8364;&#8220;S36; discussion S36-8., S26&#226;&#8364;&#8220;S36. <br />           Germany). Equal volume 2   La&#194;&#168;mmli added, samples incubated                         23. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and <br />           95 1C 5 min kept RT 5 min centrifugation 5 min                       neurodegenerative disorders. Mol Cell Biochem 2010; 345: 91&#226;&#8364;&#8220;104. <br />                                                                                                              24. Sun L, Gu L, Wang S, Yuan J, Yang H, Zhu J et al. N-acetylcysteine protects against <br />           13 000   g subsequent SDS-PAGE analysis. Blots probed primary <br />                                                                                                                  apoptosis modulation group I metabotropic glutamate receptor activity. PLoS <br />           antibodies a-tubulin (Abcam) aSyn (Sigma) respective secondary                         ONE 2012; 7: e32503. <br />           antibodies.                                                                                        25. Berman AE, Chan WY, Brennan AM, Reyes RC, Adler BL, Suh SW et al. N-acetylcysteine <br />                                                                                                                  prevents loss dopaminergic neurons EAAC1-/- mouse. Ann Neurol 2011; 69: <br />                                                                                                                  509&#226;&#8364;&#8220;520. <br />           Conflict Interest                                                                               26. Clark J, Clore EL, Zheng K, Adame A, Masliah E, Simon DK. Oral N-acetyl-cysteine <br />           The authors declare conflict interest.                                                           attenuates loss dopaminergic terminals alpha-synuclein overexpressing mice. PLoS <br />                                                                                                                  ONE 2010; 5: e12333. <br />                                                                                                              27. Bagh MB, Maiti AK, Jana S, Banerjee K, Roy A, Chakrabarti S. Quinone oxyradical <br />           Acknowledgements. This work supported Austrian Science Fund                                 scavenging properties N-acetylcysteine prevent dopamine mediated inhibition Na &#195;&#190; , <br />           FWF (Grants T414-B09 V235-B09 SB, Grant S-9304-B05 FM DC-G,                              K &#195;&#190; -ATPase mitochondrial electron transport chain activity rat brain: implications in <br />           P23490-B12 FM WNR, P24381-B20 FM TE, LIPOTOX FM DR                                neuroprotective therapy Parkinson&#226;&#8364;&#8482;s disease. Free Radic Res 2008; 42: 574&#226;&#8364;&#8220;581. <br />           DK-MCD FM LH), European Research Council (ERC NT),                           28. Yen K, Gitsham P, Wishart J, Oliver SG, Zhang N. An improved tetO promoter replacement <br />                                                                                                                  regulating expression yeast genes. Yeast 2003; 20: 1255&#226;&#8364;&#8220;1262. <br />           European Commission (Apo-Sys FM TE), Scientific Research Flanders <br />                                                                                                              29. Bonilla M, Nastase KK, Cunningham KW. Essential role calcineurin response to <br />           (Grant G.0498.09 GC), University Leuven (to JW Grant OT/07/069                        endoplasmic reticulum stress. EMBO J 2002; 21: 2343&#226;&#8364;&#8220;2353. <br />           GC), Herculus funding (Grant HER/08/066 GC) FWO-Vlaanderen                      30. Miseta A, Fu L, Kellermayer R, Buckley J, Bedwell DM. The Golgi apparatus plays a <br />           IWT-Vlaanderen (SBO-NeuroTarget JW).                                                                significant role maintenance Ca2 &#195;&#190; homeostasis vps33Delta vacuolar <br />                                                                                                                  biogenesis mutant Saccharomyces cerevisiae. J Biol Chem 1999; 274: 5939&#226;&#8364;&#8220;5947. <br />                                                                                                              31. Martin DC, Kim H, Mackin NA, Maldonado-Ba&#194;&#180;ez L, Evangelista CC Jr, Beaudry VG et al. <br />            1. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M.                            New regulators high affinity Ca2 &#195;&#190; influx revealed genome-wide <br />               Alpha-synuclein Lewy bodies. Nature 1997; 388: 839&#226;&#8364;&#8220;840.                                         screen yeast. J Biol Chem 2011; 286: 10744&#226;&#8364;&#8220;10754. <br />            2. Kruger R, Kuhn W, Mu&#194;&#168;ller T, Woitalla D, Graeber M, Ko&#194;&#168;sel S et al. Ala30Pro <span id='am-242' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-243' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-249' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-257' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-262' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-265' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-268' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-269' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-275' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-284' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-291' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-293' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-315' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-317' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-318' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-319' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span>mutation</span>   32. Locke EG, Bonilla M, Liang L, Takita Y, Cunningham KW. A homolog voltage-gated <br />               gene encoding alpha-synuclein Parkinson&#226;&#8364;&#8482;s disease. Nat.Genet 1998; 18: 106&#226;&#8364;&#8220;108.                 Ca(2 &#195;&#190; ) channels stimulated depletion secretory Ca(2 &#195;&#190; ) yeast. Mol Cell Biol <br />            3. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al.                        2000; 20: 6686&#226;&#8364;&#8220;6694. <br />               alpha-Synuclein locus triplication causes Parkinson&#226;&#8364;&#8482;s disease. Science 2003; 302: 841.         33. Du&#194;&#168;rr G, Strayle J, Plemper R, Elbs S, Klee SK, Catty P et al. The medial-Golgi ion pump <br />            4. Zarranz JJ, Alegre J, Go&#194;&#180;mez-Esteban JC, Lezcano E, Ros R, Ampuero I et al. The new                Pmr1 supplies yeast secretory pathway Ca2 &#195;&#190; Mn2 &#195;&#190; required for <br />               mutation, E46K, alpha-synuclein causes Parkinson Lewy body dementia.                        glycosylation, sorting, endoplasmic reticulum-associated protein degradation. Mol Biol <br />               Ann.Neurol. 2004; 55: 164&#226;&#8364;&#8220;173.                                                                     Cell 1998; 9: 1149&#226;&#8364;&#8220;1162. <br />            5. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M et al. Comparison             34. Cunningham KW. Acidic calcium stores Saccharomyces cerevisiae. Cell Calcium 2011; <br />               kindreds parkinsonism alpha-synuclein genomic multiplications. Ann. Neurol                50: 129&#226;&#8364;&#8220;138. <br />               2004; 55: 174&#226;&#8364;&#8220;179.                                                                             35. Ton V-K, Mandal D, Vahadji C, Rao R. Functional expression yeast human <br />            6. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al. Mutation           secretory pathway Ca(2 &#195;&#190; ), Mn(2 &#195;&#190; )-ATPase defective Hailey-Hailey disease. <br />               alpha-synuclein gene identified families Parkinson&#226;&#8364;&#8482;s disease. Science 1997; 276:           J Biol Chem 2002; 277: 6422&#226;&#8364;&#8220;6427. <br />               2045&#226;&#8364;&#8220;2047.                                                                                     36. Mandal D, Woolf TB, Rao R. Manganese selectivity pmr1, yeast secretory pathway <br />            7. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T et al. &#226;&#8364;&#732;Rejuvenation&#226;&#8364;&#8482; protects           ion pump, defined residue gln783 transmembrane segment 6. Residue Asp778 is <br />               neurons mouse models Parkinson&#226;&#8364;&#8482;s disease. Nature 2007; 447: 1081&#226;&#8364;&#8220;1086.                       essential cation transport. J Biol Chem 2000; 275: 23933&#226;&#8364;&#8220;23938. <br />            8. Cal&#196;&#177;` T, Ottolini D, Brini M. Mitochondria, calcium, endoplasmic reticulum stress       37. Olanow CW. Manganese-induced parkinsonism Parkinson&#226;&#8364;&#8482;s disease. Ann N Y Acad <br />               Parkinson&#226;&#8364;&#8482;s disease. Biofactors 2011; 37: 228&#226;&#8364;&#8220;240.                                                 Sci 2004; 1012: 209&#226;&#8364;&#8220;223. <br />            9. Lowe R, Pountney DL, Jensen PH, Gai WP, Voelcker NH. Calcium(II) selectively induces           38. Pal PK, Samii A, Calne DB. Manganese neurotoxicity: review clinical features, imaging <br />               alpha-synuclein annular oligomers interaction C-terminal domain. Protein Sci          pathology. Neurotoxicology 1999; 20: 227&#226;&#8364;&#8220;238. <br />               2004; 13: 3245&#226;&#8364;&#8220;3252.                                                                           39. Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ et al. Alpha-synuclein <br />           10. Adamczyk A, Strosznajder JB. Alpha-synuclein potentiates Ca2 &#195;&#190; influx voltage-             diverse highly conserved interaction network includes PARK9 and <br />               dependent Ca2 &#195;&#190; channels. Neuroreport 2006; 17: 1883&#226;&#8364;&#8220;1886.                                         manganese toxicity. Nat Genet 2009; 41: 308&#226;&#8364;&#8220;315. <br />  <br />  <br /> Cell Death Differentiation <br />                                                                                                     PMR1 regulates a-synuclein toxicity <br />                                                                                                    S Bu <br />                                                                                                       &#194;&#168;ttner et al <br />                                                                                                                                                                                                         477 <br />  <br /> 40. Covy JP, Giasson BI. a-Synuclein, leucine-rich repeat kinase-2, manganese           52. Niedenthal RK, Riles L, Johnston M, Hegemann JH. Green fluorescent protein a <br />     pathogenesis Parkinson disease. Neurotoxicology 2011; 32: 622&#226;&#8364;&#8220;629.                              marker gene expression subcellular localization budding yeast. Yeast 1996; 12: <br /> 41. Covy JP, Waxman EA, Giasson BI. Characterization cellular protective effects                 773&#226;&#8364;&#8220;786. <br />     ATP13A2/PARK9 expression alterations resulting pathogenic mutants.                    53. Madeo F, Herker E, Maldener C, Wissing S, La&#194;&#168;chelt S, Herlan M et al. A caspase-related <br />     J Neurosci Res 2012; 90: 2306&#226;&#8364;&#8220;2316.                                                                protease regulates apoptosis yeast. Mol Cell 2002; 9: 911&#226;&#8364;&#8220;917. <br /> 42. Tan J, Zhang T, Jiang L, Chi J, Hu D, Pan Q et al. Regulation intracellular manganese       54. Herker E, Jungwirth H, Lehmann KA, Maldener C, Fro&#194;&#168;hlich KU, Wissing S et al. <br />     homeostasis Kufor-Rakeb syndrome-associated ATP13A2 protein. J Biol Chem 2011;                  Chronological aging leads apoptosis yeast. J Cell Biol 2004; 164: 501&#226;&#8364;&#8220;507. <br />     286: 29654&#226;&#8364;&#8220;29662.                                                                              55. Bu&#194;&#168;ttner S, Eisenberg T, Carmona-Gutierrez D, Ruli D, Knauer H, Ruckenstuhl C et al. <br /> 43. Settivari R, Levora J, Nass R. The divalent metal transporter homologues SMF-1/2 mediate           Endonuclease G regulates budding yeast life death. Mol Cell 2007; 25: 233&#226;&#8364;&#8220;246. <br />     dopamine neuron sensitivity caenorhabditis elegans models manganism                  56. Kellermayer R, Szigeti R, Kellermayer M, Miseta A. The intracellular dissipation cytosolic <br />     parkinson disease. J Biol Chem 2009; 284: 35758&#226;&#8364;&#8220;35768.                                             calcium following glucose re-addition carbohydrate depleted Saccharomyces cerevisiae. <br /> 44. Wei Y, Marchi V, Wang R, Rao R. An N-terminal EF hand-like motif modulates ion                     FEBS Lett 2004; 571: 55&#226;&#8364;&#8220;60. <br />     transport Pmr1, yeast Golgi Ca(2 &#195;&#190; )/Mn(2 &#195;&#190; )-ATPase. Biochemistry 1999; 38:            57. Gupta SS, Ton VK, Beaudry V, Rulli S, Cunningham K, Rao R. Antifungal activity of <br />     14534&#226;&#8364;&#8220;14541.                                                                                       amiodarone mediated disruption calc <br /> </body></html>